Drug (if Trial Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD applicable) <Information obtained primarily from Lex Machina™ and public sources on the Internet. If any errors are identified, please contact Lisa Mandrusiak at Oblon.> Enzymotec USA, Inc.; Enzymtoec Ltd.; Aker Neptune Technologies & IPR2014-00003 8,278,351 1-Oct-13 BioMarien ASA Bioressources Inc. Instituted Final written decision Some claims upheld Apotex Holdings, Inc.; IPR2014-00115 Tygacil® 7,879,828 1-Nov-13 Apotex Inc. Wyeth LLC Instituted Final written decision All inst. claims upheld Neptune Technologies & IPR2014-00126 8,383,675 7-Nov-13 Aker BioMarine ASA Bioressources Inc. N/A Settled pre-institution N/A Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of IPR2014-00160 Opana® ER 7,851,482 18-Nov-13 New York LLC Endo Pharmaceuticals, Inc. Instituted Claims disclaimed N/A IPR2014-00315 8,318,738 31-Dec-13 PRISM Pharma Co., Ltd. CHOONGWAE PHARMA CORP. N/A Settled pre-institution N/A BioDelivery Sciences IPR2014-00325 Suboxone® 8,475,832 15-Jan-14 International, Inc. RB Pharmaceuticals Ltd. Instituted Final written decision All inst. claims unpatentable EI Dupont De Nemours and IPR2014-00331 8,312,672 8-Jan-14 Co. Monsanto Technology LLC Denied N/A N/A EI Dupont De Nemours and IPR2014-00332 8,071,845 8-Jan-14 Co. Monsanto Technology LLC Denied N/A N/A EI Dupont De Nemours and IPR2014-00333 7,832,143 8-Jan-14 Co. Monsanto Technology LLC Denied N/A N/A IPR2014-00360 Opana® ER 8,329,216 16-Jan-14 Amneal Pharmaceuticals LLC Endo Pharmaceuticals, Inc. Instituted Final written decision All inst. claims upheld IPR2014-00361 Opana® ER 8,309,122 16-Jan-14 Amneal Pharmaceuticals LLC Endo Pharmaceuticals, Inc. Denied Time barred N/A Onsolis™; Bunavail™; IPR2014-00376 Belbuca™ 7,579,019 22-Jan-14 MonoSol Rx LLC Arius Two, Inc. Instituted Final written decision All inst. claims upheld Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00377 Jentadueto® XR 6,635,280 24-Jan-14 Purdue Pharma L.P. Depomed, Inc. Instituted Final written decision All inst. claims upheld Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00378 Jentadueto® XR 6,340,475 24-Jan-14 Purdue Pharma L.P. Depomed, Inc. Instituted Final written decision All inst. claims upheld Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00379 Jentadueto® XR 6,340,475 24-Jan-14 Purdue Pharma L.P. Depomed, Inc. Instituted Final written decision All inst. claims upheld Enviro Tech Cehmical IPR2014-00382 7,728,132 27-Jan-14 LENROC COMPANY Services, Inc. Denied N/A N/A IPR2014-00398 8,299,032 31-Jan-14 3-D Matrix, Ltd. Menicon Co. Ltd. Denied N/A N/A Vireo Systems, Inc; Board of Complete Nutrition Holdings Regents of the University of IPR2014-00451 8,354,450 20-Feb-14 Inc. Nebraska Instituted Settled post-institution N/A Neptune Technologies & IPR2014-00466 8,383,675 27-Feb-14 Enzymotec Ltd. Bioressources Inc. N/A Settled pre-institution N/A IPR2014-00506 6,974,569 12-Mar-14 Conopco, Inc. dba Unilever The Procter & Gamble Co. Denied N/A N/A IPR2014-00507 6,451,300 12-Mar-14 Conopco, Inc. dba Unilever The Procter & Gamble Co. Denied N/A N/A University of Washington; Oxford Nanopore UAB Research Foundation; IPR2014-00512 8,673,550 18-Mar-14 Technologies Ltd. The Illumina, Inc. Denied N/A N/A University of Washington; Oxford Nanopore UAB Research Foundation; Claims disclaimed; final IPR2014-00513 8,673,550 18-Mar-14 Technologies Ltd. The Illumina, Inc. Instituted written decision Some claims upheld Noven Pharmaceuticals, Inc.; Novartis AG; LTS Lohmann IPR2014-00549 Exelon® 6,316,023 2-Apr-14 Mylan Pharmaceuticals, Inc. Therapie-Systeme AG Instituted Final written decision All inst. claims unpatentable Noven Pharmaceuticals, Inc.; LTS Lohmann Therapie- IPR2014-00550 Exelon® 6,335,031 2-Apr-14 Mylan Pharmaceuticals, Inc. Systeme AG; Novartis AG Instituted Final written decision All inst. claims unpatentable IPR2014-00559 6,448,274 1-Apr-14 Torrent Pharmaceuticals Ltd. Merck Frosst Canada & Co. Denied N/A N/A Enzymotec Ltd.; Enzymotec Neptune Technologies & IPR2014-00556 8,278,351 4-Apr-14 USA, Inc. Bioressources Inc. Instituted Final written decision All inst. claims unpatentable Butamax (TM) Advanced IPR2014-00581 8,273,565 4-Apr-14 Biofules LLC Gevo Inc. Denied N/A N/A Neptune Technologies & IPR2014-00586 8,278,351 11-Apr-14 Enzymotec Ltd. Bioressources Inc. N/A Settled pre-institution N/A IPR2014-00628 6,649,155 15-Apr-14 Conopco, Inc. dba Unilever The Procter & Gamble Co. Denied N/A N/A Neptune Technologies & IPR2014-00636 8,278,351 23-Apr-14 Enzymotec Ltd. Bioressources Inc. N/A Settled pre-institution N/A Glumetza®; Gralise®; IPR2014-00651 Invokamet® XR 6,723,340 17-Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Denied N/A N/A Glumetza®; Gralise®; IPR2014-00652 Invokamet® XR 6,723,340 17-Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Instituted Final written decision All inst. claims unpatentable Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00653 Jentadueto® XR 6,340,475 17-Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Denied N/A N/A Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00654 Jentadueto® XR 6,340,475 17-Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Instituted Final written decision All inst. claims upheld Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00655 Jentadueto® XR 6,635,280 17-Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Denied N/A N/A Proquin® XR; Glumetza®; Gralise®; Janumet® XR; IPR2014-00656 Jentadueto® XR 6,635,280 17-Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Instituted Final written decision All inst. claims upheld IPR2014-00676 8,337,856 17-Apr-14 Phigenix, Inc. ImmunoGen, Inc. Instituted Final written decision All inst. claims upheld Los Angeles Biomedical Research Inst. at Harbor-UCLA IPR2014-00693 8,133,903 25-Apr-14 Lilly USA, LLC; Eli Lilly & Co. Medical Center Instituted Final written decision All inst. claims upheld IPR2014-00731 Astepro™ 8,071,073 7-May-14 Impax Laboratories, Inc. Meda Pharmaceuticals Inc. N/A Settled pre-institution N/A Lucerne Biosciences, LLC; LCS IPR2014-00739 8,318,813 9-May-14 Shire Development LLC Group, LLC Instituted Claims disclaimed N/A Los Angeles Biomedical Research Inst. at Harbor-UCLA IPR2014-00752 8,133,903 13-May-14 Lilly USA, LLC; Eli Lilly & Co. Medical Center Instituted Final written decision All inst. claims unpatentable Torrent Pharmaceuticals Ltd.; Mylan Pharmaceuticals, Inc.; Mitsubishi Tanabe Pharma IPR2014-00784 Gilenya™ 8,324,283 27-May-14 Apotex Inc. Corp.; Novartis AG Instituted Final written decision All inst. claims unpatentable IPR2014-00796 5,989,569 21-May-14 CAO Group The Procter & Gamble Co. Denied N/A N/A IPR2014-00797 6,045,811 21-May-14 CAO Group The Procter & Gamble Co. Denied N/A N/A IPR2014-00798 7,122,199 21-May-14 CAO Group The Procter & Gamble Co. Denied N/A N/A ImmunoGen, Inc.; Genentech, IPR2014-00842 7,575,748 29-May-14 Phigenix, Inc. Inc. Denied N/A N/A IPR2014-00868 Glucotrol XL® RE44459 30-May-14 PACK Pharmaceuticals, LLC Alza Corporation N/A Settled pre-institution N/A Trizivir®; Epzicom®; ViiV Healthcare Co.; Viiv IPR2014-00876 Triumeq® 6,417,191 2-Jun-14 Apotex Inc. Healthcare UK Ltd. Instituted Settled post-institution N/A Viread™; Truvada®; IPR2014-00885 Atripla® 5,922,695 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A Viread™; Truvada®; IPR2014-00886 Atripla® 5,935,946 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A Viread™; Truvada®; IPR2014-00887 Atripla® 5,977,089 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A Viread™; Truvada®; IPR2014-00888 Atripla® 6,043,230 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A Baxter Healthcare Corp; Grifols, Inc.; Grifols S.A.; IPR2014-00899 6,462,180 4-Jun-14 Kamada, Ltd. Grifols Therapeutics, Inc. Instituted Final written decision All inst. claims unpatentable IPR2014-00929 6,372,428 10-Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR2014-00930 6,416,714 10-Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR2014-00931 6,352,854 10-Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR2014-00932 6,352,854 10-Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR2014-00933 6,352,854 10-Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A Enviro Granulation, LTD; Plant IPR2014-00939 6,884,756 11-Jun-14 Science, Inc. The Andersons, Inc. Denied N/A N/A Enviro Granulation, LTD; Plant IPR2014-00941 8,574,631 11-Jun-14 Science, Inc. The Andersons, Inc. Denied N/A N/A BioDelivery Sciences IPR2014-00998 Suboxone® 8,475,832 20-Jun-14 International, Inc. RB Pharmaceuticals Ltd. Denied N/A N/A Senju Pharmaceutical Co.; Johnson Mattey Inc.; Mayne Bausch & Lomb Pharma Pharma Group Ltd.; Metrics, Holdings Copr.; Bausch & IPR2014-01041 Prolensa® 8,129,431 26-Jun-14 Inc. Lomb Inc. Instituted Settled post-institution N/A Senju Pharmaceutical Co.; Johnson Mattey Inc.; Mayne Bausch & Lomb Pharma Pharma Group Ltd.; Metrics, Holdings Copr.; Bausch & IPR2014-01043 Prolensa® 8,669,290 26-Jun-14 Inc. Lomb Inc. Instituted Settled post-institution N/A LEO Pharma, Inc.; LEO Pharma Medac Gesellschaft Fur IPR2014-01091 Rasuvo® 8,664,231 1-Jul-14 A/S; Antares Pharma Inc. Klinische Instituted Settled post-institution N/A IPR2014-01093 7,955,794 2-Jul-14 Ariosa Diagnostics, Inc.